D. E. Shaw & Co., Inc. Atara Biotherapeutics, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $1.3 Million - $1.61 Million	-37,100 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $1.05 Million - $1.54 Million	30,000 Added 422.54%	37,100 $1.36 Million
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $127,800 - $343,285	7,100 New	7,100 $277,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $776M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.